Xinzhou Li, 10% Owner at NovaBay Pharmaceuticals, Inc. (NBY), bought 120,000 shares at $1.20 ($144K) on 2012-12-11, disclosed to the SEC on 2013-01-03.
Open-market purchase of $144k NBY by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| NBY | BUY | 2013-01-02 | $1.5M | — | Filing → |